Stock News & Analysis

Doximity connects U.S. medical professionals through a cloud-based digital platform serving healthcare and pharmaceutical clients.

The technology company's recent results may or may not be what the market was led to believe.

Microsoft stock rarely gets this cheap.

The next 12 months will be important for the drugmaker.

It's never too early to start thinking about this.

Will Samsung's thirst for profits blow up Micron's booming DRAM business?

Both Direxion Daily S&P 500 Bull 3X Shares and ProShares Ultra QQQ both magnify daily moves, but they magnify very different parts of the market. This ETF comparison explains why that distinction matters especially when volatility rises.

People don't trust AI, but they do trust Reddit.

The iBuying leader could be an undervalued growth stock.

Quantum computing stocks are on sale right now.

Shares of the big-box retailer have soared by 167% over the past five years.

The stock has been fairly stable over the past year.

The stock hasn't been trading around these levels since June of last year.

Monday.com couldn't rebuff the panic over AI disruption in the software sector.

Run through these key questions before packing your bags.

Explore how differences in sector focus, risk, and diversification set these leveraged ETFs apart for tech-focused investors.

Already primed for bullishness, investors got the nudge they were waiting for, then took the ball and ran with it.

Novo Nordisk is suing Hims & Hers -- but Hims & Hers already surrendered.

This top-performing exchange-traded fund (ETF) doesn't have "AI" in its name, but it remains the best AI ETF for long-term investors.

Palantir is delivering unbelievable growth, but the stock is valued at too much of a premium for me.